48 related articles for article (PubMed ID: 10353598)
21. Cytoplasmic signalling domains: the next generation.
Bork P; Schultz J; Ponting CP
Trends Biochem Sci; 1997 Aug; 22(8):296-8. PubMed ID: 9270302
[TBL] [Abstract][Full Text] [Related]
22. Knowing when to let go.
Paquin N; Chartrand P
Nat Struct Mol Biol; 2005 Dec; 12(12):1026-7. PubMed ID: 16327771
[No Abstract] [Full Text] [Related]
23. Spatial cycles mediated by UNC119 solubilisation maintain Src family kinases plasma membrane localisation.
Konitsiotis AD; Roßmannek L; Stanoev A; Schmick M; Bastiaens PIH
Nat Commun; 2017 Jul; 8(1):114. PubMed ID: 28740133
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine phosphorylation of lamin A by Src promotes disassembly of nuclear lamina in interphase.
Chu CT; Chen YH; Chiu WT; Chen HC
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34385357
[TBL] [Abstract][Full Text] [Related]
25. Regulation of Fibroblast Cell Polarity by Src Tyrosine Kinase.
Katoh K
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33535441
[TBL] [Abstract][Full Text] [Related]
26. Regulation of SRC family kinases in human cancers.
Sen B; Johnson FM
J Signal Transduct; 2011; 2011():865819. PubMed ID: 21776389
[TBL] [Abstract][Full Text] [Related]
27. Global impact of oncogenic Src on a phosphotyrosine proteome.
Luo W; Slebos RJ; Hill S; Li M; Brábek J; Amanchy R; Chaerkady R; Pandey A; Ham AJ; Hanks SK
J Proteome Res; 2008 Aug; 7(8):3447-60. PubMed ID: 18563927
[TBL] [Abstract][Full Text] [Related]
28. In vivo kinetics of mRNA splicing and transport in mammalian cells.
Audibert A; Weil D; Dautry F
Mol Cell Biol; 2002 Oct; 22(19):6706-18. PubMed ID: 12215528
[TBL] [Abstract][Full Text] [Related]
29. Recent progress of Src SH2 and SH3 inhibitors as anticancer agents.
Lu XL; Cao X; Liu XY; Jiao BH
Curr Med Chem; 2010; 17(12):1117-24. PubMed ID: 20158477
[TBL] [Abstract][Full Text] [Related]
30. The Src module: an ancient scaffold in the evolution of cytoplasmic tyrosine kinases.
Shah NH; Amacher JF; Nocka LM; Kuriyan J
Crit Rev Biochem Mol Biol; 2018 Oct; 53(5):535-563. PubMed ID: 30183386
[TBL] [Abstract][Full Text] [Related]
31. Regulation of mRNA splicing and transport by the tyrosine kinase activity of src.
Gondran P; Dautry F
Oncogene; 1999 Apr; 18(16):2547-55. PubMed ID: 10353598
[TBL] [Abstract][Full Text] [Related]
32. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
[TBL] [Abstract][Full Text] [Related]
34. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
35. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
